Harvard Kennedy School Researcher Publishes New Study Findings on Economics (The Health Costs of Cost Sharing).

A new study conducted by researchers at Harvard Kennedy School examines the health consequences of drug interruptions caused by sudden changes in medication prices. The study finds that when patients face smaller budgets for medications, they consume fewer drugs and have a higher mortality rate. The research also reveals that high-risk patients, who would benefit the most from certain drugs, are more likely to cut back on them. The study concludes that cost sharing, rather than curbing waste, is inefficient and leads to missed opportunities for affordable healthcare. [Extracted from the article]

Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)